COMSATS and Syndesis Health Join Hands for Genomic Sequencing Programs

COMSATS and Syndesis Join Hands

Syndesis Health announced today that it has signed a Memorandum of Understanding (MoU) with the Commission on Science and Technology for Sustainable Development in the South (COMSATS) for genomic sequencing programs.

An intergovernmental organization, COMSATS presently has 27 developing countries as members across Africa, Asia, and Latin America. The MoU provides a broad framework for collaborative activities aimed at providing better healthcare to the citizens of these member countries, supporting curative drug development, and devising guidelines to help in managing pharmaceutical products. 

Ambassador Dr. Mohammad Nafees Zakaria, Executive Director, COMSATS, and Mr. Kamil Mehmood, Co-Founder & Director of Syndesis Health, signed the MoU on behalf of their respective organizations at a ceremony hosted by COMSATS Secretariat in Islamabad. Event participants included heads and representatives of diplomatic missions of COMSATS' Member States in Islamabad, senior officials of relevant ministries, as well as media representatives. 

Addressing the participants, Ambassador Zakaria, the Executive Director COMSATS, shared his thoughts on the agreement and its prospects for research, impact on the industrial sector, and economy. He commented that the MOU demonstrates a mutual desire to support each other in endeavors to keep pace with rapid developments in science and technology, ensuring better healthcare for all through effective utilization of modern-day technologies. The Director of Syndesis Health, Mr. Mehmood assured the full support of Syndesis Health to COMSATS in implementing the related programs. 

Ambassador Zakaria and Mr. Mehmood briefed the media and the distinguished participants on how the collaboration would utilize the latest technological know-how for strengthening the healthcare sector, reducing healthcare costs, and contributing to the national economy.

About Syndesis Health

Syndesis Health accelerates research and innovation for healthcare and life sciences companies. The company was founded on the potential for real-world clinical data to advance medical research, improve patient health outcomes, and inform healthcare policy decisions. The Syndesis Health Network enables secure collaboration amongst member organizations and is empowered by the Syndesis Data Platform, which provides secure, centralized access to global real-world data sets sourced from numerous healthcare institutions. The data is comprised of millions of de-identified patient journeys, representing a diverse population of patients across many common and rare diseases. Visit our website at to learn more.

Source: Syndesis Health